Lotte Biologics offers drug substance manufacturing services for biopharmaceuticals.
Latest News
- Lotte Group says reports of Lotte Healthcare's Theragen Health sale remain ‘unconfirmed’ - KBR
- Lotte Biologics' new leadership struggles to brush off doubts - 코리아타임스
- Lotte Biologics names new CEO in pursuit of market expansion - MSN
- Lotte Biologics names new CEO for global business expansion - MSN
- Lotte Biologics Names James Park as its New CEO - CEO Insights Asia
- Lotte Biologics names new CEO in pursuit of market expansion - The Korea JoongAng Daily
- Lotte Biologics appoints James Park as new CEO - KBR
- Lotte Biologics names new CEO for global business expansion - 코리아타임스
- Lotte Biologics hires pharma veteran as new CEO - The Korea Herald
- Lotte Biologics has appointed James Park (58), a former vice president of Samsung Biologics, as its - 매일경제
- Lotte Biologics Names James Park Former GC Cell CEO As New CEO - SportsChosun
- Lotte Group's Largest Executive Reshuffle in History: 36% of CEOs Replaced - BusinessKorea
- Lotte heir assumes management role amid liquidity concerns - The Investor
- Lotte announces leadership reshuffle, promotes Shin Yoo-yeol to vice president - 조선일보
- Lotte Biologics runs internship program open to all - The Investor